Inhibition of p53-mediated transactivation and cell cycle arrest by E1A through its p300/CBP-interacting regionSelfcloseTable (original) (raw)
- Original Paper
- Published: 06 March 1997
Oncogene volume 14, pages 1047–1057 (1997)Cite this article
- 640 Accesses
- 162 Citations
- Metrics details
Abstract
Cellular transformation by the adenovirus E1A oncoprotein requires its p300/CBP- and Rb-binding domains. We mapped inhibition of p53-mediated transactivation to the p300/CBP-binding region of E1A. An E1A mutant incapable of physically interacting with Rb retained the capacity to inhibit transactivation by p53, whereas E1A mutants of the p300/CBP-interacting domain failed to inhibit p53. The inhibitory effect of the p300/CBP-binding region of E1A on p53 was demonstrated with p53-activated reporters and endogenous p53 targets such as p21WAF1/CIP1 or MDM2. E1A lacking the capacity to interact with Rb, but capable of p300/CBP interaction, was competent in suppression of a DNA-damage activated p53-dependent cell cycle checkpoint. Exogenous CBP and p300 were able to individually relieve E1A's inhibitory effect on p53-mediated transcription. Mutants of E1A that are not capable of interacting with p300 or CBP were found to efficiently stabilize endogenous p53 but were not competent in repression of p21 expression thus dissociating these two effects of E1A. Our results suggest that the p300/CBP-binding domain of E1A inhibits a p53-dependent cellular response which normally inhibits DNA replication following Adenovirus infection.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Similar content being viewed by others
Author information
Authors and Affiliations
- Department of Medicine and Genetics, Howard Hughes Medical Institute, Laboratory of Molecular Oncology and Cell Cycle Regulation, University of Pennsylvania School of Medicine and Comprehensive Cancer Center, Philadelphia, 19104, Pennsylvania, USA
Kumaravel Somasundaram & Wafik S El-Deiry
Authors
- Kumaravel Somasundaram
You can also search for this author inPubMed Google Scholar - Wafik S El-Deiry
You can also search for this author inPubMed Google Scholar
Additional information
This work was presented at the Cold Spring Harbor Laboratory Meeting on 'Cancer Genetics and Tumor Suppressor Genes', August 14–18, 1996
Rights and permissions
About this article
Cite this article
Somasundaram, K., El-Deiry, W. Inhibition of p53-mediated transactivation and cell cycle arrest by E1A through its p300/CBP-interacting regionSelfcloseTable.Oncogene 14, 1047–1057 (1997). https://doi.org/10.1038/sj.onc.1201002
- Received: 24 May 1996
- Revised: 17 December 1996
- Accepted: 18 December 1996
- Issue Date: 06 March 1997
- DOI: https://doi.org/10.1038/sj.onc.1201002